We are live on ! Find out more
CDTX

Cidara Therapeutics
CDTX

Delisted

CDTX was delisted on the 6th of January, 2026.

Back to rankings

46 hedge funds and large institutions have $154M invested in Cidara Therapeutics in 2015 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 14 increasing their positions, 11 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

58% more capital invested

Capital invested by funds: $97.1M → $154M (+$56.6M)

27% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 11

4% less funds holding

Funds holding: 48 → 46 (-2)

17% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 12

Holders
46
Holders Change
-2
Holders Change %
-4.17%
% of All Funds
1.2%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.05%
New
10
Increased
14
Reduced
11
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BB
BB Biotech
Switzerland
+$7.01M
2
Goldman Sachs
Goldman Sachs
New York
+$3.22M
3
EAM
Eventide Asset Management
Massachusetts
+$1.33M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$516K
5
SIM
Spark Investment Management
New York
+$494K

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$3.89M
2
DM
Deerfield Management
New York
-$1.77M
3
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$1.54M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$823K
5
Millennium Management
Millennium Management
New York
-$757K

CDTX Hedge Fund Activity: Q4 2015 in Review

46 of the 3,823 institutional investors tracked by Wall St. Rank reported a position in Cidara Therapeutics (CDTX) for Q4 2015, worth a combined $154M — up 58% from $97.1M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of CDTX and 10 opened new positions — a net loss of 2 holders — while 11 trimmed existing stakes and 14 added.

The largest buyer was BB Biotech, opening a new position worth an estimated $7.01M. The largest seller was Sabby Management, exiting entirely with an estimated $3.89M sold.

  • 46 institutional investors held Cidara Therapeutics (CDTX) as of Q4 2015, down from 48 in Q3 2015.
  • Funds reported $154M of Cidara Therapeutics stock for Q4 2015, up 58% quarter-over-quarter.
  • 10 funds opened new Cidara Therapeutics positions in Q4 2015 and 12 closed out, a net change of -2 holders.
  • The largest Cidara Therapeutics buyer in Q4 2015 was BB Biotech, an estimated $7.01M added.
  • The largest Cidara Therapeutics seller in Q4 2015 was Sabby Management, an estimated $3.89M sold.

Based on aggregated 13F filings for Q4 2015.